CNEQ vs TCHP

Alger Concentrated Equity ETF against T. Rowe Price Blue Chip Growth ETF: cost, size, returns, what they hold and how much of it is the same.

Overlap by weight
54%
15 shared positions
Fee gap
1 bp
CNEQ is cheaper
1-year return gap
9.7 pts
CNEQ is ahead
Larger fund
TCHP
$2.2B

Side by side

CNEQTCHP
FundAlger Concentrated Equity ETFT. Rowe Price Blue Chip Growth ETF
IssuerAlgerT. Rowe Price
CategoryTechnologySemiconductors
Expense ratio0.56%0.57%
Assets$732M$2.2B
Average daily dollar volume$9.1M$7.8M
ListedApr 4, 2024Aug 4, 2020
FrenzyCap score4858
1-month return−4.9%−2.2%
3-month return+1.3%+4.8%
Year to date+14.0%+1.6%
1-year return+12.9%+3.2%
30-day volatility20.1%16.4%
Worst drawdown, 1 year−19.7%−17.5%
Trailing 12-month yield0.46%—
Holdings3067
Top 10 weight61.9%56.7%
Look-through P/E31.128.2
Holdings vs fair value+1.3%−0.6%
Holdings above 200-day average63%58%
Net flow, latest 3 reported months+$203M thru Jun 2026+$95M thru Jun 2026
30-day implied volatility——
Holdings as ofas of Oct 2, 2026third-party dataas of Jun 30, 2026SEC filing

Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.

Largest shared holdings

70% of CNEQ · 59% of TCHP
HoldingCNEQTCHP
NVDA15.19%15.95%
GOOG6.10%6.31%
AVGO4.68%5.96%
AAPL5.09%4.54%
MSFT8.11%4.38%
META3.81%3.51%
AMZN4.18%3.32%
MU3.50%2.62%
TSLA2.76%2.61%
AMD2.13%3.64%
LLY1.58%3.20%
GEV2.63%1.11%
TSM6.22%1.06%
SE2.22%0.40%
SPCX2.06%0.33%

Sector mix of the stock holdings

SectorCNEQTCHPGap
Technology68.0%63.8%+4.2%
Industrials8.7%15.3%−6.6%
Consumer Discretionary6.9%10.3%−3.4%
Health Care3.8%5.0%−1.2%
Utilities3.9%0.4%+3.6%
Financials1.3%2.5%−1.2%
Communication Services0.0%2.0%−2.0%
Materials0.0%0.4%−0.4%
Consumer Staples0.0%0.0%−0.0%

More: full overlap table · CNEQ holdings · TCHP holdings

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.